Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Sonic hedgehog connects podocyte injury to mesangial activation and glomerulosclerosis
Dong Zhou, … , Donna B. Stolz, Youhua Liu
Dong Zhou, … , Donna B. Stolz, Youhua Liu
Published October 10, 2019
Citation Information: JCI Insight. 2019;4(22):e130515. https://doi.org/10.1172/jci.insight.130515.
View: Text | PDF
Research Article Nephrology

Sonic hedgehog connects podocyte injury to mesangial activation and glomerulosclerosis

  • Text
  • PDF
Abstract

Glomerular disease is characterized by proteinuria and glomerulosclerosis, two pathologic features caused by podocyte injury and mesangial cell activation, respectively. However, whether these two events are linked remains elusive. Here, we report that sonic hedgehog (Shh) is the mediator that connects podocyte damage to mesangial activation and glomerulosclerosis. Shh was induced in glomerular podocytes in various models of proteinuric chronic kidney diseases (CKD). However, mesangial cells in the glomeruli, but not podocytes, responded to hedgehog ligand. In vitro, Shh was induced in podocytes after injury and selectively promoted mesangial cell activation and proliferation. In a miniorgan culture of isolated glomeruli, Shh promoted mesangial activation but did not affect the integrity of podocytes. Podocyte-specific ablation of Shh in vivo exhibited no effect on proteinuria after adriamycin injection but hampered mesangial activation and glomerulosclerosis. Consistently, pharmacologic blockade of Shh signaling decoupled proteinuria from glomerulosclerosis. In humans, Shh was upregulated in glomerular podocytes in patients with CKD and its circulating level was associated with glomerulosclerosis but not proteinuria. These studies demonstrate that Shh mechanistically links podocyte injury to mesangial activation in the pathogenesis of glomerular diseases. Our findings also illustrate a crucial role for podocyte-mesangial communication in connecting proteinuria to glomerulosclerosis.

Authors

Dong Zhou, Haiyan Fu, Yang Han, Lu Zhang, Shijia Liu, Lin Lin, Donna B. Stolz, Youhua Liu

×

Figure 3

Shh selectively promotes mesangial cell activation in glomerular miniorgan culture ex vivo.

Options: View larger image (or click on image) Download as PowerPoint
Shh selectively promotes mesangial cell activation in glomerular miniorg...
(A) Representative micrographs show that Shh did not significantly affect podocyte integrity and ultrastructure ex vivo. Isolated glomeruli from normal rats were incubated in the absence or presence of Shh (50 ng/ml) for 24 hours. Transmission electron microscopy (TEM) demonstrates that podocyte foot processes and slit diaphragm were largely preserved after Shh incubation. Arrows indicate slit diaphragm. Dotted lines indicate the boundary of glomerular basement membrane. Scale bar: 25 μm (top); 500 nm (bottom). (B and C) Western blots show that Shh did not affect the abundance of podocyte-specific proteins, such as nephrin, podocalyxin, α-actinin-4, and WT1, ex vivo. Representative Western blot (B) and quantitative data (C) are presented (n = 3, t test). (D and E) Western blots show that Shh induced mesangial cell activation in glomerular miniorgan culture. Isolated glomeruli were incubated with Shh (50 ng/ml) for 24 hours, and glomerular lysates were immunoblotted with antibodies against PDGFR-β, fibronectin, α-SMA, β-catenin, and α-tubulin, respectively. Representative Western blot (D) and quantitative data (E) are presented. *P < 0.05 versus controls (n = 3, t test). (F and G) Immunofluorescence staining shows that Shh did not change the expression and localization of podocyte-specific proteins ex vivo. Isolated glomeruli were incubated without or with Shh for 24 hours, and glomerular sections were immunostained for nephrin, podocalyxin, and α-actinin-4 proteins. Representative micrographs (F) and quantitation of immunofluorescence (IF) intensity (arbitrary unit) (G) are shown. Data were obtained from 3 glomeruli per experiment; 3 independent experiments per group. Arrows indicate positive staining. Scale bar: 20 μm. (H and I) Double staining shows that Shh selectively promoted mesangial cell activation. Isolated glomeruli were incubated without or with Shh for 24 hours and subjected to double immunostaining for podocyte marker nestin (green) and mesangial cell marker PDGFR-β (red). Representative micrographs (H) and quantitation of IF intensity (arbitrary unit) (I) are shown. *P < 0.05 versus controls, t test. Data were obtained from 3 glomeruli per experiment; 3 independent experiments per group. White arrows indicate PDGFR-β+ mesangium, whereas yellow arrows denote nestin+ podocytes. Scale bar: 20 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts